These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 26297305)

  • 1. Mechanisms of vasorelaxation induced by the cannabidiol analogue compound O-1602 in the rat small mesenteric artery.
    Al Suleimani YM; Al Mahruqi AS; Hiley CR
    Eur J Pharmacol; 2015 Oct; 765():107-14. PubMed ID: 26297305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular pharmacology of a novel cannabinoid-like compound, 3-(5-dimethylcarbamoyl-pent-1-enyl)-N-(2-hydroxy-1-methyl-ethyl)benzamide (VSN16) in the rat.
    Hoi PM; Visintin C; Okuyama M; Gardiner SM; Kaup SS; Bennett T; Baker D; Selwood DL; Hiley CR
    Br J Pharmacol; 2007 Nov; 152(5):751-64. PubMed ID: 17891160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasodilator actions of abnormal-cannabidiol in rat isolated small mesenteric artery.
    Ho WS; Hiley CR
    Br J Pharmacol; 2003 Apr; 138(7):1320-32. PubMed ID: 12711633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of vasorelaxation induced by oleoylethanolamide in the rat small mesenteric artery.
    AlSuleimani YM; Hiley CR
    Eur J Pharmacol; 2013 Feb; 702(1-3):1-11. PubMed ID: 23340219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasorelaxant effects of oleamide in rat small mesenteric artery indicate action at a novel cannabinoid receptor.
    Hoi PM; Hiley CR
    Br J Pharmacol; 2006 Mar; 147(5):560-8. PubMed ID: 16415907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms involved in oleamide-induced vasorelaxation in rat mesenteric resistance arteries.
    Sudhahar V; Shaw S; Imig JD
    Eur J Pharmacol; 2009 Apr; 607(1-3):143-50. PubMed ID: 19326479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasorelaxant activities of the putative endocannabinoid virodhamine in rat isolated small mesenteric artery.
    Ho WS; Hiley CR
    J Pharm Pharmacol; 2004 Jul; 56(7):869-75. PubMed ID: 15233865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The endogenous lipid N-arachidonoyl glycine is hypotensive and nitric oxide-cGMP-dependent vasorelaxant.
    Al Suleimani YM; Al Mahruqi AS
    Eur J Pharmacol; 2017 Jan; 794():209-215. PubMed ID: 27890711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery.
    White R; Hiley CR
    Br J Pharmacol; 1997 Dec; 122(8):1573-84. PubMed ID: 9422801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB1 activation.
    Stanley CP; Hind WH; Tufarelli C; O'Sullivan SE
    Cardiovasc Res; 2015 Sep; 107(4):568-78. PubMed ID: 26092099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity in the mechanisms of vasorelaxation to anandamide in resistance and conduit rat mesenteric arteries.
    O'Sullivan SE; Kendall DA; Randall MD
    Br J Pharmacol; 2004 Jun; 142(3):435-42. PubMed ID: 15148250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen receptor subtypes mediate distinct microvascular dilation and reduction in [Ca2+]I in mesenteric microvessels of female rat.
    Mazzuca MQ; Mata KM; Li W; Rangan SS; Khalil RA
    J Pharmacol Exp Ther; 2015 Feb; 352(2):291-304. PubMed ID: 25472954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The GPR55 agonist lysophosphatidylinositol relaxes rat mesenteric resistance artery and induces Ca(2+) release in rat mesenteric artery endothelial cells.
    AlSuleimani YM; Hiley CR
    Br J Pharmacol; 2015 Jun; 172(12):3043-57. PubMed ID: 25652040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Endothelium in Abnormal Cannabidiol-Induced Vasoactivity in Retinal Arterioles.
    Su EN; Kelly ME; Cringle SJ; Yu DY
    Invest Ophthalmol Vis Sci; 2015 Jun; 56(6):4029-37. PubMed ID: 26098470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of Delta9-tetrahydrocannabinol in rat mesenteric vasculature, and its interactions with the endocannabinoid anandamide.
    O'Sullivan SE; Kendall DA; Randall MD
    Br J Pharmacol; 2005 Jun; 145(4):514-26. PubMed ID: 15821751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical cannabinoid stimulates endothelial cell migration via a Gi/Go-coupled receptor distinct from CB1, CB2 or EDG-1.
    Mo FM; Offertáler L; Kunos G
    Eur J Pharmacol; 2004 Apr; 489(1-2):21-7. PubMed ID: 15063151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Curcumin-Induced Vasorelaxation in Rat Superior Mesenteric Arteries.
    Zhang H; Liu H; Chen Y; Zhang Y
    Ann Vasc Surg; 2018 Apr; 48():233-240. PubMed ID: 28943490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G protein-coupled endothelial receptor for atypical cannabinoid ligands modulates a Ca2+-dependent K+ current.
    Begg M; Mo FM; Offertaler L; Bátkai S; Pacher P; Razdan RK; Lovinger DM; Kunos G
    J Biol Chem; 2003 Nov; 278(46):46188-94. PubMed ID: 12952947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor.
    Offertáler L; Mo FM; Bátkai S; Liu J; Begg M; Razdan RK; Martin BR; Bukoski RD; Kunos G
    Mol Pharmacol; 2003 Mar; 63(3):699-705. PubMed ID: 12606780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelium-independent relaxation to cannabinoids in rat-isolated mesenteric artery and role of Ca2+ influx.
    Ho WS; Hiley CR
    Br J Pharmacol; 2003 Jun; 139(3):585-97. PubMed ID: 12788818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.